A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of OP-101 After Intravenous Administration in Healthy Volunteers
Clinical trial NCT03500627 · COMPLETED
Trial details
- NCT number
- NCT03500627
- Sponsor
- Orpheris, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-30
- Primary completion
- 2018-07-20
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.